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ABSTRACT: We investigated the feasibility of using spatially-offset Raman spectroscopy (SORS) for non-destructive characterisation 
of bone tissue engineering scaffolds. The deep regions of these scaffolds, or scaffolds implanted subcutaneously in live animals, are 
typically difficult to measure by confocal Raman spectroscopy techniques because of the limited depth penetration of light caused by 
the high level of light scattering. Layered samples consisting of bioactive glass foams (IEIC16), 3D-printed biodegradable poly-(lactic-co-
glycolic acid) scaffolds (PLGA) and hydroxyapatite powder (HA) were used to mimic non-destructive detection of bio-mineralisation for 
intact real-size 3D tissue engineering constructs. SORS spectra were measured with a new SORS instrument using a digital micro-mirror 
device (DMD) to allow software selection of the spatial offsets. The results show that HA can be reliably detected at depths of 0-2.3 mm, 
which corresponds to the maximum accessible spatial offset of the current instrument. The intensity ratio of Raman bands associated 
to the scaffolds and HA with the spatial offset depended on the depth at which HA was located. Furthermore, we show the feasibility 
for in-vivo monitoring mineralisation of scaffold implanted subcutaneously by demonstrating the ability to measure transcutaneously 
Raman signals of the scaffolds and HA (fresh chicken skin used as a top layer). The ability to measure spectral depth profiles at high 
speed (5 s acquisition time), and the ease of implementation, make SORS a promising approach for non-invasive characterisation of 
cell/tissue development in-vitro, and for long-term in-vivo monitoring the mineralisation in 3D scaffolds subcutaneously implanted in 
small animals. 
INTRODUCTION 
Tissue engineering combines human cells and scaffold 
materials to grow tissues in the laboratory to replace diseased or 
damaged tissue parts in patients1. Tissue engineering is envisaged 
to fulfil the increasing demand for tissue grafts as well as to 
enable tailoring their biological properties to meet the 
requirements of individual patients (size, shape, immune-
compatibility, etc). Vital to the further development of this 
technology and the associated widespread medical 
implementation of tissue engineering products is the availability 
of non-invasive techniques to monitor the in-vitro growth of the 
tissue. In-vitro studies are required to optimize the mechanical 
properties and biological activity of the scaffolds and engineered 
grafts. However, more relevant information regarding the clinical 
performance of the engineered tissues can be obtained from 
longitudinal in-vivo studies where the grafts are implanted in 
small animals. In such in-vivo studies, there is a need for non-
invasive tools to monitor the temporal and spatial the 
development of the grafts after implantation, but at the same 
time minimize the number of animals used. For example, in 
bone tissue engineering, it is important to measure non-
destructively the chemical properties of the tissue in order to 
monitor the formation and mineralization of the extracellular 
matrix throughout the entire graft. Currently, the performance 
of engineered tissue constructs is mostly assessed by conventional 
destructive methods, such as histological analysis2.  
Raman spectroscopy (RS) is a well-established analytical tool 
for measuring non-invasively live cells3-6 and bone tissue7-9. RS has 
been used to measure the deposition of hydroxyapatite (HA) (the 
mineral phase of bone) on various types of bone tissue 
engineering scaffolds10,11 and characterize the mineralization of 
osteoblast cultures in-vitro12-15. Because RS requires no exogenous 
labels, information regarding the composition of the mineral 
deposits and their evolution in time can be measured1.  
Nevertheless, the interrogation of cellular behavior and 
tissue/extra-cellular matrix formation at deeper depths within 
the 3D scaffold, by optical techniques still remains 
challenging.17,18 So far, non-destructive RS measurements of 
scaffold-based tissue engineering constructs have been limited to 
monitoring the interaction of cell and biomaterial on the surface 
of 3D scaffold10,19. The porous scaffolds play a critical role in 
tissue engineering, as they provide a fine structure for cell 
seeding, proliferation and new tissue formation. However, the 
porous structure of the scaffolds (typical pore size 50-300 µm) 
leads to a high level of light scattering, thus limiting the 
penetration of light in the scaffolds. In-vivo measurements of 
grafts implanted in animals are even more difficult because of the 
need for light to penetrate through layers of soft tissue. Spatially-
 offset Raman spectroscopy (SORS) is a novel technique for 
measuring depth-related chemical and physical properties of 
samples that exhibit high levels of light scattering, and has been 
verified as an effective tool for subsurface Raman analysis20,21. 
SORS allowed the measurement of subsurface chemical 
information in diffusely scattering samples, typically from depths 
of 20 µm – 5 mm range, which is beyond the reach of confocal 
RS. Furthermore, SORS has been used for in-vivo transcutaneous 
measurements of bone quality in small animals22,23 and 
humans24,25.  
In this paper, we investigated the feasibility of using SORS 
for measuring non-destructively spectral depth-profiling of intact 
3D bone tissue engineering scaffolds, under conditions 
mimicking both in-vitro growth and in-vivo development after 
subcutaneous implantation in patients or model animals. We 
present measurements on two common types of scaffolds: i) 
bioactive glass foams (IEIC16), scaffolds with a broad range of 
inter-connected pores (pore range 50-200 µm); ii) 3D-printed 
poly-(lactic-co-glycolic acid) scaffolds (PLGA), which had a well-
defined structure with ~200 µm pores. Bioactive glass and PLGA 
are among the most popular and widely used materials for 
scaffolds in bone tissue engineering26. The former is a 
representative of bioactive materials able to bond to human 
tissue, while the latter represents the synthetic polymer family 
which exhibit tailorable and reproducible physical, chemical and 
biodegradation properties. Here, a SORS instrument based on a 
digital-mirror-device (DMD) 27 was used to measure Raman 
spectral depth-profiles of the scaffold/HA layered samples, 
demonstrating the potential of SORS to monitor the sub-surface 
mineralization of the scaffolds in-situ. The detection of HA is 
important in bone tissue engineering because the formation of 
hydroxyapatite (HA) within the scaffold is a step occurring to 
bone bonding, thus it is an indication of the scaffold 
bioactivity26. 
MATERIALS AND METHODS 
Spatially offset Raman spectroscopy (SORS). All Raman 
spectroscopy measurements were carried out with a purpose-built 
SORS instrument based on a digital-mirror-device (DMD) to 
allow software selection of the spatial offsets. For excitation, the 
beam of a Ti:sapphire laser (3900S SpectraPhysics) tuned at 785 
nm wavelength and 2 mm beam diameter, was focused on the 
sample by a 2/0.06 NA microscope objective with 11 mm 
diameter entrance pupil (Olympus, Plan N). The laser power at 
the sample was 170 mW, and the diameter of the laser spot was 
illuminating an area of 88 μm. The back-scattered Raman 
photons were collected by the same objective, and focused by a 
lens (focal length 200 mm) onto a DMD (Texas Instruments, 
0.30 WVGA chipset) connected to a PC using mini HDMI 
connection, and controlled by a home-built LabVIEW program. 
The DMD consisted of a 608 × 684 array of individually 
addressable micro-mirrors (7.6×7.6 µm2). The individual micro-
mirrors can be switched to one of two states, ‘on’ and ‘off’, 
corresponding to a tilt of ±12°, allowing light at arbitrary spatial 
positions to be reflected towards the spectrometer (tilt +12°), 
whilst the remaining light is rejected (tilt -12°).  The DMD was 
placed in the collection path of the Raman spectrometer at a 
sample-conjugate plane, serving as the offset controller for 
SORS, as well as a slit/pinhole for the spectrometer27. For all 
SORS measurements, a semi-annulus collection geometry was 
selected, where the width of the annulus was 0.08 mm and the 
radius was defined by the spatial offset value (see Supporting 
Information Fig. S1). The area of the Raman collection region at 
the sample surface represented ~25% of the total area of the full 
annulus corresponding to a spatial offset value27.  
The Raman photons reflected by the DMD were collected by 
another lens (focal length of 100 mm), passed through a long 
filter (BLP01-785R-25, Semrock) and analyzed with an imaging 
spectrometer (Acton LS785, Princeton Instruments USA) with a 
1000 g/mm plane ruled diffraction grating (Richardson 
Gratings, USA), and a 256×1024 pixel CCD camera (Newton 
BR-DD, Andor UK).  
Tissue engineering scaffolds. Micrographs and scanning 
electron microscopy (SEM) images of the tissue engineering 
scaffolds investigated in this study are presented in Figure 1.  
The composition of the IEIC16 bioactive scaffolds was 49.46 
SiO2, 36.27 CaO, 6.6 Na2O, 1.07 P2O5 and 6.6 K2O, in mol %. 
The scaffolds were produced by the gel cast foaming processing, 
as described elsewhere, where bioactive glass particle slurry is 
foamed with a surfactant and the foam set in place using a gelling 
agent (polymer) before sintering28. The modal interconnected 
pore diameter was 400 μm and interconnects estimated to be 100 
μm measured by mercury porosimetry. The SEM image (Figure 
1(b)) shows the interconnected macro-porous network, which 
can serve as template for tissue growth in 3D. 
The poly-(lactic-co-glycolic acid) (PLGA) scaffolds (Figure 1(c) 
and (d) for the optical and SEM images) were 3D printed on a 
REGENHU 3D bioprinter. PLGA 85:15 (Mw= 50 kDa Evonik 
Industries) was extruded at a temperature of 120 °C onto a 50 
°C heated platform. The printhead travelled at a speed of 12 
mm/s and the pressure for printing PLGA was 4 bar.29 The 
PLGA 3D-printed scaffolds have well-defined structure and 
regular pore size, and the distribution of pore size is centralized, 
result in a higher transparency and porosity, see Figure 1(c). SEM 
image (Figure 1(d)) reveals that the pore size is about 200 μm. 
Hydroxyapatite powder ([Ca5(OH)(PO4)3]x), with particle 
size < 200m, was purchased from Sigma Aldrich (CAS number: 
12167-74-7). Fresh chicken skin samples (thickness 0.5 - 1 mm) 
were obtained from a local supermarket. Samples were kept at 
4C prior to measurements. 
RESULTS AND DISCUSSION 
SORS measurements of IEIC16 bioactive glass 
scaffold/HA/scaffold sandwiched structure. To mimic a 
measurement configuration for sub-surface detection of HA 
within an intact 3D porous scaffold, ~3 mm thick layer of 
hydroxyapatite (HA) powder was placed between two layers of 
IEIC16 foam, as schematically presented in Figure 2(a). The size 
of the sandwiched samples was 9 mm × 9 mm. The thickness of 
the scaffold sublayer was 1 mm, while the thickness of the top 
scaffold layer was varied (d = 0.5 mm, 1 mm and 2.0 mm) to 
mimic in-situ detection of HA at different depths within the 3D 
scaffold. Semi-annulus collection geometry was employed for all 
SORS measurements as it provides the high collection efficiency 
for the Raman photons.27 The SORS spectra measured for the 
IEIC16 scaffold/HA layered samples are presented in Figure 2 
(b) and (c), and compared to the Raman spectra of pure IEIC16 
scaffold and HA powder. Figure 2 shows that the most intense 
band in the Raman spectrum of HA corresponds to the PO43- 
 symmetric stretching at 962 cm-1. The small peak at 1045 cm-1 
also belongs to PO43- tetrahedral and corresponds to P-O 
asymmetric stretching. The Raman spectra of IEIC16 foams are 
dominated by a broad photoluminescence bands in the range 
1200 - 2000 cm-1. The SORS results in Figure 2(b) show that, for 
a IEIC16 top layer of 0.5 mm thickness, increasing the spatial 
offset value leads to an increase in the intensity of the Raman 
band associated to the HA sublayer (962 cm-1) relative to 1390 
cm-1 band assigned to the IEIC16 scaffold. Similar behavior is 
observed when the thickness of the top layer is increased to 1 
mm and 2 mm. The results demonstrate that the sampling depth 
for SORS experiments of IEIC16 scaffold can be as deep as 2.0 
mm, indicating the capability of SORS for depth profiling in 
scaffold-based tissue engineering study. Larger penetration depth 
may be achieved by replacing the DMD in the setup with one 
that has a larger active area, and/or by using a tube-lens with a 
shorter focal length when imaging onto the DMD, both of which 
will increase the available field of view for spatially-offset 
modulation. 
Figure 3 shows the dependence of the relative intensities of 
the bands corresponding to the IEIC16 scaffold and HA on the 
spatial offset and the thickness of the scaffold top layer. The data 
were obtained by integrating the area under the Raman bands at 
962 cm-1 and 1390 cm-1. For both bands, local linear baselines 
were used for background subtraction. Three sets of data points 
were calculated from measured SORS spectra sample structures 
with IEIC16 scaffold top layer of thicknesses 0.5 mm, 1.0 mm 
and 2.0 mm. The results show that the Raman intensity ratio 
R=I962/I1390 increased as the spatial offset was increased, for all 
top layer thicknesses. When the thickness of the top layer was 0.5 
mm, the ratio of Raman signals from the subsurface HA layer to 
surface IEIC16 layer, when changing the spatial offset from 0 to 
1 mm, was R(1 mm)/R(0 mm)=~3.7. This value reduced to R(1 
mm)/R(0 mm)=2 when the thickness of the top layer was 
increase to 2 mm. In addition, the absolute values of the I962/I1390 
ratio decreased as the thickness d of top scaffold layer increases. 
These findings are consistent with the increase in the number of 
detected Raman photons generated in the sub-surface HA layer 
when the spatial offset is increased: more photons generated in 
the deeper HA layer that are scattered towards the surface of the 
sample, and reach the surface at larger offset distance where they 
can be detected. However, increasing the spatial offset leads to a 
decrease in the number of detected photons generated in the top 
layers, as these photons typically reach the surface of the sample 
at lower offset values. Indeed, for a given spatial offset, increasing 
the thickness of the top layer leads to a higher contribution of 
Raman photons from the top layer and lower from the deeper 
layers.  
Our results represent an important step forward from the 
earlier work. For example, Jones et al used Raman spectroscopy 
to monitor chondrocyte behavior on the surface of bioactive glass 
scaffolds10 and Moimas et al investigated the effect of bioactive 
glass scaffold degradation in simulated body fluid over time19. 
However, these studies measured chemical and biological 
information non-destructively only from the surface of the 
scaffolds. Our results shown here demonstrate the feasibility of 
using SORS to sample deeper and retrieve information, such as 
mineralization, from sub-surface regions of bioactive scaffolds as 
deep as 2 mm. 
SORS measurements on PLGA scaffold/HA layered 
structure. 
SORS measurements on PLGA scaffolds with thickness of 
0.8 mm, 1.7 mm and 2.3 mm were performed using the same 
DMD-based SORS instrument. A ~ 3 mm thick layer of HA 
powder at the back of the scaffolds to serve as a sublayer in the 
sample structure, see Figure 4(a). A thin quartz coverslip (0.17 
mm thick) was placed in between the HA and the PLGA scaffold 
to prevent HA powder from penetrating into the pores of the 
scaffold. All the SORS results were obtained by the semi-annulus 
collection geometry using the DMD. To prevent direct 
illumination of HA in the sublayer through a pore, the laser 
beam was focused on a crossbar of the solid PLGA structure. 
The SORS spectra are presented in Figure 4(b) and (c), 
respectively, and compared to the pure spectra of PLGA and HA. 
Spatial offset is indicated next to each Raman spectrum. For all 
spectra, a baseline was subtracted using a modified polynomial 
curve-fitting method described by Lieber et al 30. The SORS 
spectra show that as the value of the spatial offset increased, the 
Raman band at 872 cm-1, assigned to PLGA C-COO stretch 
vibration31 gradually decreased relative to the Raman band at 
962cm-1 assigned to HA increased. For thicker PLGA layers 
(Figure 4(c)) a similar trend was observed, although at zero spatial 
offset, no bands corresponding to HA can be detected in the 
Raman spectrum of the PLGA/HA scaffold. As the spatial offset 
is increased to 0.20 mm, the band at 962 cm-1 assigned to HA 
begins to emerge, and becomes dominant as the spatial offset is 
increased.  
Figure 5 presents the Raman intensity ratio I962 /I872 as 
function of the spatial offset and the thickness of PLGA scaffold. 
The results show that, for all samples with different thickness of 
top layer, the Raman intensity ratio of I962/I872 increased as the 
spatial offset was increased. For a thin top PLGA layer (0.8 mm), 
the R=I962 /I872 increases rapidly when spatial offsets are larger 
than ~0.4 mm. The ratio of Raman signals from the subsurface 
HA layer to surface PLGA layer, when changing the spatial offset 
from 0 to 1 mm, was R(1 mm)/R(0 mm)=~2.8. A similar trend 
is observed when the thickness of the scaffold increases, but the 
ratio tended to plateau for larger spatial offsets (> 0.6 mm). For 
a 2 mm thick top-layer, the ratio R(1 mm)/R(0 mm)=~3. This 
observation may be used to link the rate of change of the 
measured ratio I962 /I872 as a function of the spatial offset to 
estimate the depth at which HA, i.e. mineralization, is found in 
an intact 3D scaffold.   
Feasibility of detection mineralization for subcutaneously 
implanted scaffolds. After in-vitro optimization of the scaffolds, 
studies using animal models are typically used for assessing the 
performance of the tissue engineering scaffolds in more clinically 
relevant conditions. Subcutaneous implantation of engineered 
grafts in small animals is a common method to investigate 
different properties of the grafts, such as biocompatibility and 
bioactivity32. Suitable scaffolds should support and direct cell 
growth and tissue formation, replicate native 3D architecture, 
withstand mechanical and physiological loading and stresses, and 
exhibit function-dependent biodegradation without production 
of toxic by-products. Non-invasive tools for measuring the 
chemical profiles of the implanted grafts in-vivo are useful for 
measuring and monitoring these properties after implantation of 
the grafts. 
 After establishing the ability to measure spectral depth 
profiles of intact scaffolds and HA powder layers, we investigated 
whether HA could be detected in similar samples 
transcutaneously. To mimic such transcutaneous measurement 
conditions, layered samples based on fresh chicken skin, tissue 
engineering scaffolds (bioactive IEIC16 foam and 3D printed 
PLGA scaffold) and HA were prepared as schematically 
presented in Figure 6a. Figure 6b and c present the SORS spectra 
of these samples measured at different spatial offset values. 
Raman bands assigned to proteins and lipids can be identified at 
1450 cm-1 (CH2 deformations) and 1660 cm-1 (Amide I in 
proteins and C=C vibrations in and lipids)3, allowing a relatively 
clear spectral window for the detection of the 962 cm-1 Raman 
band corresponding to HA. The results show that even at zero 
spatial offset, a weak peak at 962 cm-1 can be detected, in 
particular for the sample containing the PLGA scaffold. Bands 
corresponding to the PLGA (872 cm-1) and IEIC16 bioactive 
glass are also detected. As the spatial offset is increased from 0 
mm to 1 mm, the relative intensity of the 962 cm-1 band increases 
relative to the bands corresponding to the skin. These results 
demonstrate the feasibility to detect non-invasively scaffold 
mineralization at depths of several millimeters, in transcutaneous 
measurements. The fact that bands from both HA and scaffolds 
can be detected in the SORS spectra may be useful as their 
relative intensities could be used for estimation of the level of 
mineralization these scaffolds. At the same time, the intensity 
ratio of the bands corresponding to HA and skin may be used to 
estimate the depth at which the HA is located. While these 
results demonstrate the potential of SORS for in-vivo 
transcutaneous monitoring of bone tissue-engineering scaffolds, 
further work is required to optimize the optical design and 
develop models for extracting the relevant biological information 
from the SORS spectral depth-profiles.  
CONCLUSION 
Non-destructive spectral depth profiling of two common 
types of bone tissue engineering scaffolds, bioactive glass foams 
and biodegradable poly-(lactic-co-glycolic acid) (PLGA), was 
demonstrated by spatially offset Raman spectroscopy (SORS). 
The two types of scaffolds selected in this study had a random 
porous structure (bioactive IEIC16 foam) and regular structure 
obtained by 3D printing (PLGA scaffold). For the SORS 
experiments, an instrument based on a DMD was used in order 
to allow software selection of the spatial offset and rapid 
measurements of Raman spectra (typical signal-to-noise ratio >25 
at 5 s integration time and 170 mW excitation power). In order 
to mimic in-situ detection of bone mineralization in the sub-
surface regions of the scaffolds, layered samples of scaffold and 
hydroxyapatite (HA) powder were analyzed. The detection of HA 
in bone tissue engineering scaffolds is important because the 
formation of a hydroxyapatite layer on the surface of the scaffold 
is the step preceding to bone bonding. The results show that the 
detection of HA can be achieved through layers of 2.0 mm for 
IEIC16 foam and 2.3 mm for PLGA scaffold, values that 
correspond to the maximum spatial offset of the current 
instrument. The range may be extended by optimizing the optics 
at the DMD (active area and magnification). The results also 
show that the depth at which the HA is located in the scaffold 
can be estimated non-destructively by examining the intensity 
ratio of the measured Raman bands corresponding to the 
scaffold and HA. Furthermore, the ability to detect and measure 
HA in both bioactive glass and PLGA scaffolds through an intact 
layer of skin demonstrates the feasibility for in-vivo measuring the 
mineralization of tissue engineering grafts implanted 
subcutaneously in animal models. Although the laser power used 
here was higher than the safety standard relevant to laser light on 
the skin (BS EN 60825-1:2007) in order to allow short 
acquisition times (20 seconds), no damage was observed to the 
skin layer. This observation is consistent with previous reports of 
in-vivo confocal Raman micro-spectroscopy of skin33, where a 
laser power of 100mW (730 nm wavelength) was focused to a 
spot of 1-2 μm (spot diameter in this study was 88 μm). 
Nevertheless, the feasibility of in-vivo transcutaneous SORS 
measurements using laser powers capped at the safety limits (10-
30 mW) has been demonstrated previously, but at the expense of 
longer acquisition times (60 seconds)25. However, such longer 
acquisition times are acceptable for both in-vitro and in-vivo 
measurements of tissue engineering grafts, as the biological 
changes of interest, i.e. formation and mineralization of the 
extracellular matrix, occur over periods of days and weeks. 
It is also important to mention the limitations of this study, 
mainly in terms of the phantom samples used. While two 
common types of scaffold were use, real tissue engineering grafts 
have a higher level of complexity. First, the presence of the 
collagen extracellular matrix may alter the light-scattering 
properties of the graft and generate additional Raman bands. 
The mineral composition of bone tissue is known to change 
during the development, including transformations in HA 
crystallinity. For in-vivo samples, further factors need to be 
considered, such as subcutaneous adipose tissue. 
Nevertheless, these preliminary results demonstrate the 
feasibility of using SORS as tool for non-destructive 
characterization of scaffold-based tissue engineering constructs. 
This technique may be used for monitoring the development of 
the tissue in-vitro as well as for assessing its quality prior to clinical 
use. In addition, SORS may be used repeatedly to measure 
chemical spectral depth profiles, and may be a useful tool for 
long-term longitudinal studies on animal to monitor the 
temporal and spatial development of the tissue grafts. Apart from 
a potentially better understanding of the biomaterial properties, 
this technique may also allow a reduction in the number of 
animals used in such studies. However, further research is 
required to understand the photon migration within these 
samples and the origin of the SORS signals. Recent studies using 
bone layered samples investigated the relationships between the 
spatial offsets and the location of the probed volume within bone 
samples. 34,35 Similar systematic studies would allow the 
optimization of the SORS measurements conditions for tissue 
engineering grafts (sampling volume, range of spatial offsets), as 
well as develop models for recovering the relevant information 
out of the measured spectral depth profiles. 
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Figure 1. (a) Optical microscope image and (b) SEM image of an IEIC16 bioactive glass scaffolds. (c) Optical microscope image and (d) SEM cross-section 
image of a 3D printed PLGA scaffolds. 
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Figure 2. (a) Schematic description of IEIC16 scaffold/HA/scaffold sandwich structures used in the experiments for SORS measurement. A set of spatial offset 
Raman spectra obtained from the samples consisting of (b) top layer d = 0.5 mm and (c) top layer d = 2.0 mm IEIC16 scaffold and ~ 2 mm thick layer of HA 
powder. Spatial offsets are indicated next to each Raman spectrum. Integration time for each spectrum is 5 s. Raman spectra of IEIC16 scaffold and HA 
powder (measured separately) are also shown for comparison. All spectra were normalized with respect to the maximum intensity, and then shifted vertically for 
clarity. 
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Figure 3. The ratio of Raman band intensity corresponding to the sub-surface HA layer (962 cm-1) and top layer IEIC16 bioactive glass (1390 cm-1) as a 
function of the spatial offset distance. The curves correspond to three thicknesses of the top layer: 0.5 mm, 1 mm and 2 mm. The mean values and standard 
deviations are obtained from three measurements on different locations on the sample. 
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Figure 4. (a) Schematic description of PLGA scaffold/HA layered structure. A quartz slide (~ 170 μm thickness) was placed in between the layers to 
prevent HA powder penetrate into the pores of the scaffold. A set of spatial offset Raman spectra obtained from the samples consisting of (b) top layer d = 
0.8 mm and (c) top layer d = 2.3 mm PLGA scaffold, and ~ 3 mm thick of HA powder as lower layer. Spatial offset is indicated next to each Raman 
spectrum. Integration time for each spectrum is 5 s. Raman spectra of PLGA scaffold and HA powder (measured separately) are also shown for comparison. 
All spectra were normalized with respect to the maximum intensity, and then shifted vertically for clarity. 
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Figure 5. The ratio of Raman band intensity corresponding to the deep HA layer (962 cm-1) and top PLGA layer (872 cm-1) as a function of spatial offset 
distance. The curves correspond to three thicknesses of the top layer: 0.5 mm, 1 mm and 2 mm. The mean values and standard deviations are obtained from 
three measurements on different sample locations. 
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Figure 6. (a) Schematic description of IEIC16 bioglass and PLGA scaffold/HA layered structures used to mimic transcutaneous in-vivo SORS 
measurements (fresh chicken skin used as top layer). The size of the samples was ~10 mm x 10 mm x 6 mm. (b) SORS spectra measured at different spatial 
offset values. Integration time was 20 s for each spectrum. All spectra were normalized with respect to the maximum intensity, and then shifted vertically 
for clarity. 
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